After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
PMVP belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of PMV Pharmaceuticals Inc is $96.45M. A total of 0.84 million shares were traded on the day, compared to an average of 458.49K shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, PMVP has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 3 BUYs and 3 SELLs from insiders. Insiders purchased 369,214 shares during that period but sold 95,702.
In the most recent transaction, ORBIMED ADVISORS LLC sold 87,786 shares of PMVP for 2.23 per share on Nov 22. After the transaction, the 10% Owner now owns 0 company shares. In a previous transaction on Sep 15, Alland Leila sold 6,291 shares at 6.62 per share. PMVP shares that Chief Medical Officer owns now total 45,909.
Among the insiders who sold shares, Jalota Deepika disposed of 4,104 shares on Sep 15 at a per-share price of $6.62. This resulted in the Chief Development Officer holding 29,946 shares of PMVP after the transaction.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PMVP has a high of $9.72 and a low of $1.17.
As of this writing, PMVP has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.33 per share and a lower estimate of -$0.48. The company reported an EPS of -$0.34 in the last quarter, which was 24.40% higher than expectations of -$0.45.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PMVP’s latest balance sheet shows that the firm has $297.16M in Cash & Short Term Investments as of fiscal 2021. There were $11.19M in debt and $12.22M in liabilities at the time. Its Book Value Per Share was $4.39, while its Total Shareholder’s Equity was $308.56M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PMVP is Buy with a score of 4.50.
